Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Drug: Empagliflozin 10 MG; Drug: Placebo Oral Tablet Sponsors: Ann& Robert H Lurie Children ' s Hospital of Chicago Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials